AntimetabolitesAntimetabolites, AntineoplasticTetrahydrouridineTrabeculectomyAntineoplastic AgentsFloxuridineFluorouracil6-MercaptopurineNeoplasmsMethotrexateSurgical SpongesMitomycinCytarabineDeoxycytidineLeukemia L1210ThioguanineInosine MonophosphateDrug Screening Assays, AntitumorPhosphoribosyl PyrophosphateVidarabine Phosphate6-AminonicotinamideCell SurvivalDrug SynergismTumor Cells, CulturedPantothenic AcidNorleucineFolic Acid AntagonistsDrug Resistance, NeoplasmCell DivisionPurinesDrug Evaluation, PreclinicalDrug DiscoveryDrug DesignMolecular Targeted TherapyCell CycleThymidylate SynthasePhosphonoacetic AcidAzathioprineCell LineEarly Detection of CancerCell Line, TumorApoptosisGuanineProstatic NeoplasmsBreast NeoplasmsDrug IndustryDrug ApprovalDrug Delivery SystemsGene Expression Regulation, NeoplasticDrug CostsFees, PharmaceuticalStreptomycesClinical Trials as TopicDrugs, InvestigationalAntineoplastic Combined Chemotherapy ProtocolsMice, NudeMedical OncologyUnited States Food and Drug AdministrationNeoplasm ProteinsCell ProliferationCost SharingPharmacopoeias as TopicOvarian NeoplasmsDrug Resistance, MultipleXenograft Model Antitumor AssaysLung NeoplasmsUnited StatesInhibitory Concentration 50NaphthoquinonesStomach NeoplasmsColonic NeoplasmsGene Expression ProfilingProtein Kinase InhibitorsTumor Markers, BiologicalNeoplasm MetastasisNeoplasm InvasivenessPancreatic NeoplasmsCisplatinKineticsSignal TransductionPyrimidinesCancer VaccinesBlotting, WesternDrug CarriersProto-Oncogene Proteins c-ablModels, BiologicalDose-Response Relationship, DrugEnzyme InhibitorsPiperazinesUterine Cervical NeoplasmsSurvival AnalysisGenetic Predisposition to DiseaseSurvival RateBenzamides